HE4 overexpression has been found in patients with EC as well as in patients with transitional cell carcinoma, pulmonary adenocarcinoma, breast cancer, pancreatic cancer and ovarian cancer10,33. The gene discussed is WFDC2; the disease is transitional cell carcinoma.